CA
TRIB

Commerzbank Aktiengesellschaft’s Trinity Biotech TRIB Stock Holding History

Commerzbank Aktiengesellschaft’s Portfolio TRIB Stock Details TRIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-141
Closed -$386K – 1198
2014
Q3 		$386K Sell
141
-26
-16% -$84.5K ﹤0.01% 1008
2014
Q2 		$576K Buy
167
+15
+10% +$53.3K ﹤0.01% 963
2014
Q1 		$552K Sell
152
-301
-66% -$1.18M ﹤0.01% 947
2013
Q4 		$1.76M Buy
453
+353
+353% +$1.27M 0.01% 768
2013
Q3 		$326K Buy
100
+7
+8% +$20.5K ﹤0.01% 1122
2013
Q2 		$236K Buy
+93
New +$231K ﹤0.01% 1329

Other funds holding TRIB

HA
Heartland Advisors Milwaukee, Wisconsin $2.25B AUM 44.61% 1-Year Est. Return
CCMLC
Cardinal Capital Management LLC (Connecticut) Greenwich, Connecticut $365M AUM 18.32% 1-Year Est. Return
LSC
Lyon Street Capital Sausalito, California $67M AUM
KCM
Kennedy Capital Management St Louis, Missouri $5.65B AUM 61.31% 1-Year Est. Return
TAM
THB Asset Management Norwalk, Connecticut $440M AUM 59.59% 1-Year Est. Return
AAM
ACK Asset Management Greenwich, Connecticut $856M AUM 70.44% 1-Year Est. Return
PWAM
Park West Asset Management San Francisco, California $1.47B AUM 86.42% 1-Year Est. Return
CAM
Cortina Asset Management Milwaukee, Wisconsin $1.62B AUM 15.44% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return
WA
Whitebox Advisors Minneapolis, Minnesota $7.65B AUM 13.87% 1-Year Est. Return

Commerzbank Aktiengesellschaft's TRIB Position: Q4 2014 in Review

Commerzbank Aktiengesellschaft sold out of Trinity Biotech (TRIB) in Q4 2014, closing a stake of 141 shares — an estimated $386K sold.

Commerzbank Aktiengesellschaft first reported a position in TRIB in Q2 2013 and held it in 6 quarters. The position peaked at $1.76M in Q4 2013. 92 funds tracked by Wall St. Rank hold TRIB as of Q4 2014.

  • Commerzbank Aktiengesellschaft reported no remaining Trinity Biotech position as of Q4 2014 after selling out during the quarter.
  • Commerzbank Aktiengesellschaft sold 141 Trinity Biotech shares in Q4 2014, an estimated $386K.
  • Commerzbank Aktiengesellschaft first reported a position in Trinity Biotech in Q2 2013 and held it in 6 quarters.
  • Commerzbank Aktiengesellschaft's Trinity Biotech position peaked at $1.76M in Q4 2013.
  • 92 funds tracked by Wall St. Rank held Trinity Biotech as of Q4 2014.

Based on Commerzbank Aktiengesellschaft's 13F filing for Q4 2014, filed 5 Feb 2015.